Fran White to Join the Advisory Board of Xcelerate, Inc.
February 15 2022 - 7:30AM
InvestorsHub NewsWire
Fran White to Join the Advisory Board of
Xcelerate, Inc.
Mauldin, SC -- February 15, 2022 -- InvestorsHub
NewsWire -- Xcelerate,
Inc. (OTC pink
sheets: "XCRT”)
today announced that Fran White has accepted an invitation to join
its Advisory Board effective immediately. Fran founded MDC
Associates more than 30 years ago. MDC is a consulting company
specializing in regulatory affairs management in the medical device
and biotechnology industries. Their clients include many of the
leading companies in the biotech and diagnostic industries.
Prior to founding MDC, Fran held a number of management roles
within ThermoFisher, a Fortune 500 world leader in the supply of
scientific instrumentation, consumables and software
services.
“Fran brings another
invaluable skill set to our Advisory Board,” said Michael O’Shea,
Xcelerate’s CEO. “Fran has more than 40 years’ experience providing
companies and investors with insight to the technical and financial
potential of new and existing products and technologies. This
assistance will be a great enhancement to our soon to be filed
series of patents developed by Dr. Anja Glisovic. Fran also has
extensive experience in recognizing and getting product to market
in third world countries.”
“Fran’s experience
in third world markets will no doubt also be of great assistance in
establishing our recently announced business opportunity in Africa
through AfiyaSasa Africa, LLC” commented O’Shea. “To that end, Dr.
Dilan Ellegala has been in Tanzania since the first of February
working to establish the framework of the operation in that country
and developing a beta program
there.”
“I would like to
thank our partners and investors for the continued support as we
continue to execute on our business
plan”
For more information
please visit www.xcelerate.global
SAFE
HARBOR
This press release may
contain forward-looking information within the meaning of Section
21E of the Securities Exchange Act of 1934, as amended (the
"Exchange Act"), including all statements that are not statements
of historical fact regarding the intent, belief or current
expectations of the Company, its directors or its officers with
respect to, among other things: (i) the Company's financing plans;
(ii) trends affecting the Company's financial condition or results
of operations; (iii) the Company's growth strategy and operating
strategy; and (iv) the declaration and payment of dividends. The
words "may," "would," "will," "expect," "estimate," "anticipate,"
"believe," "intend," and similar expressions and variations thereof
are intended to identify forward-looking statements. Investors are
cautioned any such forward-looking statements are not guarantees of
future performance and involve risks and uncertainties, many of
which are beyond the Company's ability to control, and actual
results may differ materially from those projected in
forward-looking statements resulting
from various
factors.
Xcelerate (QB) (USOTC:XCRT)
Historical Stock Chart
From Jan 2025 to Feb 2025
Xcelerate (QB) (USOTC:XCRT)
Historical Stock Chart
From Feb 2024 to Feb 2025